Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Conjunctival goblet cell response to vasoconstrictor use.

S Shellans1, L F Rich, I Louiselle

  • 1Weeks Ophthalmology Laboratory, Oregon Health Sciences University, Portland.

Journal of Ocular Pharmacology
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ophthalmic drops causing coma in an infant.

The Journal of pediatrics·2001
Same author

Assessment of ophthalmology residents' contact lens training.

The CLAO journal : official publication of the Contact Lens Association of Ophthalmologists, Inc·2000
Same author

Photoastigmatic refractive keratectomy in myopes. Nidek US Investigators Group.

Journal of refractive surgery (Thorofare, N.J. : 1995)·2000
Same author

Expanding the scope of lamellar keratoplasty.

Transactions of the American Ophthalmological Society·2000
Same author

Sterile interface keratitis associated with micropannus hemorrhage after laser in situ keratomileusis.

Journal of cataract and refractive surgery·1999
Same author

Sterile interface keratitis after laser in situ keratomileusis: three episodes in one patient with concomitant contact dermatitis of the eyelids.

Journal of refractive surgery (Thorofare, N.J. : 1995)·1999

Topical vasoconstrictors, like phenylephrine, do not appear to harm mucin-secreting goblet cells in the conjunctiva. This study suggests they do not negatively impact tear film adequacy with chronic use.

Area of Science:

  • Ophthalmology
  • Cell Biology

Background:

  • Ophthalmic vasoconstrictors (e.g., phenylephrine, naphazoline) reduce conjunctival hyperemia.
  • Chronic use of these agents is suspected to cause dry-eye symptoms.
  • The mechanism may involve reduced mucin-secreting goblet cells affecting tear film adequacy.

Purpose of the Study:

  • To investigate if topical vasoconstrictor use impacts tear film adequacy.
  • To determine if vasoconstrictors decrease mucin-secreting goblet cells in the conjunctiva.

Main Methods:

  • Conjunctival impressions were obtained from rabbit eyes using cellulose acetate filter strips.
  • Animals were treated with vasoconstrictors or artificial tears over various time periods.
  • Goblet cell density was quantified per light microscopic field.

Related Experiment Videos

Main Results:

  • No significant difference in goblet cell counts was observed between vasoconstrictor-treated and control groups.
  • Goblet cell density remained unaffected across different treatment durations.

Conclusions:

  • Topical vasoconstrictor use does not significantly affect conjunctival goblet cell density.
  • These findings suggest vasoconstrictors may not impair tear film adequacy by depleting goblet cells.